Accessibility Menu
 
EMVision Medical Devices logo

EMVision Medical Devices

(ASX) EMV

Current Price$1.55
Market Cap$146.84M
Since IPO (2018)+418%
5 Year-43%
1 Year-16%
1 Month-7%

EMVision Medical Devices Financials at a Glance

Market Cap

$146.84M

Revenue (TTM)

$9.62M

Net Income (TTM)

$16.39M

EPS (TTM)

$-0.12

P/E Ratio

-13.46

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$1.55

Volume

30,137

Open

$1.58

Previous Close

$1.55

Daily Range

$1.54 - $1.58

52-Week Range

$1.48 - $2.43

EMV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EMVision Medical Devices

Industry

Healthcare Equipment and Supplies

CEO

Scott Kirkland

Headquarters

Macquarie Park, NSW 2113, AU

EMV Financials

Key Financial Metrics (TTM)

Gross Margin

86%

Operating Margin

-8%

Net Income Margin

-7%

Return on Equity

-58%

Return on Capital

-56%

Return on Assets

-41%

Earnings Yield

-7.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$146.84M

Shares Outstanding

92.94M

Volume

30.14K

Short Interest

0.00%

Avg. Volume

40.88K

Financials (TTM)

Gross Profit

$5.05M

Operating Income

$8.13M

EBITDA

$8.71M

Operating Cash Flow

$7.84M

Capital Expenditure

$50.37K

Free Cash Flow

$7.89M

Cash & ST Invst.

$10.53M

Total Debt

$3.53M

EMVision Medical Devices Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$214.72K

-103.3%

Gross Margin

0.00%

N/A

Market Cap

$146.84M

N/A

Market Cap/Employee

$3.19M

N/A

Employees

46

N/A

Net Income

$3.97M

-3423.5%

EBITDA

$7.69M

-101.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$13.54M

+145.8%

Accounts Receivable

$5.75M

+311.8%

Inventory

$0.00

N/A

Long Term Debt

$3.77M

+1872.9%

Short Term Debt

$250.44K

-91.0%

Return on Assets

-40.90%

N/A

Return on Invested Capital

-55.76%

N/A

Free Cash Flow

$6.00M

-338.8%

Operating Cash Flow

$5.94M

-348.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONE.AXOneview Healthcare PLC
$0.20+2.63%
LDX.AXLumos Diagnostics Holdings Limited
$0.17-7.89%
ALC.AXAlcidion Group Limited
$0.10+0.00%
AVH.AXAVITA Medical, Inc.
$1.30+8.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$61.70+0.05%
NOKNokia
$9.54+0.01%
NVDANvidia
$183.89+0.01%
NIONio
$6.08-0.05%

Questions About EMV

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.